Showing results (1751-1760 of 1,895) with videos related to

Sort By:
Pageof 190
Gene Therapy|December 5, 2014
Widespread correction of central nervous system disease after intracranial gene therapy in a feline model of Sandhoff diseaseV J McCurdy, H E Rockwell, J R Arthur, et al.
American Journal of Hematology|April 4, 2020
Risk of invasive fungal infections in patients with high-risk MDS and AML receiving hypomethylating agentsGee Youn Geeny Kim, Jonathan Burns, Craig W Freyer, et al.
Science Translational Medicine|April 11, 2014
Sustained normalization of neurological disease after intracranial gene therapy in a feline modelVictoria J McCurdy, Aime K Johnson, Heather L Gray-Edwards, et al.
Gastroenterology|June 23, 2026
Proactive Fecal Calprotectin Home Monitoring in Ulcerative Colitis: Results of a Prospective Randomized Control TrialGregory Rosenfeld, Neeraj Narula, Yvette Leung, et al.
Research Square|March 30, 2023
Haploidentical Donor Blood or Marrow Transplantation for Myelodysplastic/Myeloproliferative Overlap Neoplasms: Results from a North American CollaborationTania Jain, Hua-Ling Tsai, Hany Elmariah, et al.
Blood Cancer Journal|December 8, 2023
Real world data on outcomes of anti-CD38 antibody treated, including triple class refractory, patients with multiple myeloma: a multi-institutional report from the Canadian Myeloma Research Group (CMRG) DatabaseA Visram, A De La Torre, D White, et al.
JCI Insight|November 23, 2021
p300 or CBP is required for insulin-stimulated glucose uptake in skeletal muscle and adipocytesVitor F Martins, Samuel A LaBarge, Alexandra Stanley, et al.
JCI Insight|October 14, 2016
Maternal obesity reduces oxidative capacity in fetal skeletal muscle of Japanese macaquesCarrie E McCurdy, Simon Schenk, Byron Hetrick, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 5, 2023
Pharmacokinetic and Pharmacodynamic Consequences of Cytochrome P450 3A Inhibition on Mitragynine Metabolism in RatsShyam H Kamble, Samuel Obeng, Francisco León, et al.
Annals of Intensive Care|December 16, 2023
Angiotensin II treatment is associated with improved oxygenation in ARDS patients with refractory vasodilatory shockDaniel E Leisman, Damian R Handisides, Lakhmir S Chawla, et al.
Pageof 190